YAMAUCHI MOTOTAKA

Profiles

Profiles

• 氏名

  YAMAUCHI MOTOTAKA

Affiliation

• Department of Diabetes, Endocrinology and Hematology

Research achievements

Published Papers

Original paper
• Isolated Adrenocorticotropic Hormone Deficiency and Severe Hypercalcemia After Destructive Thyroiditis in a Patient on Nivolumab Therapy With a Malignant Melanoma., Takebayashi K, Ujiie A, Kubo M, Furukawa S, Yamauchi M, Shinozaki H, Suzuki T, Naruse R, Hara K, Tsuchiya T, Inukai T., 10(4), 358-362, Apr. 2018
• Seasonal variations and the influence of COVID-19 pandemic on hemoglobin A1c，glycoalbumin，and low-density lipoprotein cholesterol．Diabetol, Takebayashi K，Yamauchi M，Hara K，Tsuchiya T，Hashimoto K．, Diabetol Int., 13(4), 599-605, Oct. 2022
• Association of skin autofluorescence with serum lipids, insulin secretion ability and diabetic complications in patients with poorly controlled type 2 diabetes., Takebayashi K, Tsuchiya T, Shinozaki H, Yamauchi M, Suzuki T, Hara K, Inukai T, Hashimoto K., Dokkyo Med J., 2022
• Switching from a dipeptidyl peptidase (DPP)-4 inhibitor to oral semaglutide in patients with poorly controlled type 2 diabetes: an observational study., Takebayashi K, Yamauchi M, Hara K, Tsuchiya T, Hashimoto K., Dokkyo Med J., 2022
• Effects of telemedicine on the management of diabetes mellitus in the COVID-19 pandemic- A single center study-., Furukawa S, Kawai S, Yamauchi M, Shinozaki H, Ujiie A, Okumura T, Kubo M, Suzuki S, Asai K, Takii H, Hara K, Miyakawa K, Hara K, Tsuchiya T, Takebayashi K, Hashimoto K, Dokkyo Med J, 2023
• Analysis of five cases showing false-high Hemoglobin A1c due to reduced catalase activity, Hara K, Ujiie A, Suzuki S, Okumura T, Kubo M, Shinozaki H, Yamauchi M, Tsuchiya T, Takebayashi K, Shimozawa N, Koga M, Hashimoto K, Endocr J., 71, 39-44, 2024
• Changing from a Dipeptidyl Peptidase (DPP)-4 Inhibitor to Oral Semaglutide in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Observational Study., Takebayashi K, Yamauchi M, Hara K, Tsuchiya T, Hashimoto K., Dokkyo Medical J., 2(Jun), 123-129, 2023
• Association of the ratio of glycoalbumin to hemoglobin A1c with season change and the COVID-19 pandemic in patients with type 2 diabetes mellitus., Takebayashi K, Yamauchi M, Hara K, Tsuchiya T, Hashimoto K., Cureus, 2024
• Long term effect of oral semaglutide on glycemic control. An extensional observational study with the periods of 2 years from baseline., Takebayashi K, Yamauchi M, Hara K, Tsuchiya T, Hashimoto K., Dokkyo Med J, 2024
• Analysis of five cases showing false-high Hemoglobin A1c due to reduced catalase activity., Hara K, Ujiie A, Suzuki S, Okumura T, Kubo M, Shinozaki H, Yamauchi M, Tsuchiya T, Takebayashi K, Shimozawa N, Koga M, Hashimoto K., Endocr J., 71, 39-44, 2024
• Analysis of serum levels and DNA methylation of fibroblast growth factor 21 using peripheral bloodderived genomes in patients with obesity., Shinozaki H, Kawai S, Gamo-Kawasaki M, Takei A, Tsujikado K, Fukuda K, Yamauchi M, Hara K, Tsuchiya T, Takebayashi K, Hashimoto K, Endocr J., 71, 907-924, 2024
• The Changes in Blood HbA1c Levels of the Patients with Diabetes Mellitus, Who Used Teleconsultation in the COVID-19 Pandemic-A Single Center Study., Furukawa S, Kawai S, Yamauchi M, Shinozaki H, Ujiie A, Okumura T, Hashimoto K., Dokkyo Med J., 3, 1-6, 2024

Case report
• Hb Phnom Penh Showing Falsely High or Reasonable HbA1c Values Depending on the Type of High-performance Liquid Chromatography System., Hara K, Koga M, Shinozaki H, Yamauchi M, Suzuki T, Naruse R, Tsuchiya T, Takebayashi K, Inukai T, Hashimoto K., Intern Med, 59(6), 805-809, Mar. 2020

  DOI
• Severe Non-Islet Cell Hypoglycemia From Ileum-Origin Gastrointestinal Stromal Tumor Producing Insulin-Like Growth Factor-2 in a Patient With Liver Cirrhosis Due to Chronic Hepatitis B., Takebayashi K, Furukawa S, Okumura T, Kubo M, Ujiie A, Yamauchi M, Shinozaki H, Hara K, Tsuchiya T, Ono Y, Inukai T, Hashimoto K, J Clin Med Res, 12(12), 824-830, 01 Dec. 2020
• Cerebral infarction after switching from roxadustat to daprodustat in a patient with renal anemia., Takebayashi K, Yamauchi M, Hara K, Tsuchiya T, Hashimoto K., Cureus., 16, e63942, 2024
• Exacerbation in glycemic control by switching from subcutaneous dulaglutide injection to oral semaglutide administration in a patient with type 2 diabetes, who had undergone gastrectomy., Takebayashi K, Harasawa A, Miyake Y, Ujiie A, Yamauchi M, Hara K, Tsuchiya T, Hashimoto K., Dokkyo Med J., 3, 303-307, 2024